Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma

Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma

Saved in:

Bibliographic Details
Main Authors:	Chia-Hung Chien, Wen-Bin Yang, Jian-Ying Chuang, Jung-Shun Lee, Wei-An Liao, Chih-Yuan Huang, Pin-Yuan Chen, An-Chih Wu, Shun-Tai Yang, Chien-Cheng Lai, Pei-I. Chi, Jui-Mei Chu, Siao Muk Cheng, Chan-Chuan Liu, Daw-Yang Hwang, Shang-Hung Chen, Kwang-Yu Chang
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Series:	Journal of Experimental & Clinical Cancer Research
Online Access:	https://doi.org/10.1186/s13046-025-03445-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma
by: Chia-Hung Chien, et al.
Published: (2022-07-01)

Synergistic effect of perampanel with temozolomide on glioblastoma cells in vivo
by: Takuma Nishide, et al.
Published: (2025-03-01)

Kaposi’s sarcoma occurring in a glioblastoma multiforme on temozolomide
by: Jiong-Huang Lim, et al.
Published: (2025-01-01)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-05-01)

GLUT3 enhances chemosensitivity in glioblastoma by transporting temozolomide and capecitabine
by: Honglin Diao, et al.
Published: (2025-08-01)

USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma
by: Jiabing Li, et al.
Published: (2025-08-01)

Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance
by: Jianlin Pu, et al.
Published: (2025-05-01)

Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells
by: Samantha L. Gerlach, et al.
Published: (2024-09-01)

Enhanced Performance of Dye-Sensitized Solar Cells with Nanostructure Graphene Electron Transfer Layer
by: Chih-Hung Hsu, et al.
Published: (2014-01-01)

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
by: Emil Lou, et al.
Published: (2013-04-01)

P4HA1 mediates YAP hydroxylation and accelerates collagen synthesis in temozolomide-resistant glioblastoma
by: Xueru Li, et al.
Published: (2025-08-01)

Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01)

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
by: Justyna Magdalena Przystal, et al.
Published: (2019-02-01)

Combination of heme oxygenase-1 inhibitors and temozolomide to improve the anticancer effect in glioblastoma
by: Sebastiano Intagliata, et al.
Published: (2024-12-01)

Clinical outcomes and predictors in patients with acute on chronic liver failure in Southern Taiwan
by: Pao-Yuan Huang, et al.
Published: (2025-03-01)

Association between alcohol consumption and renal function in patients with diabetes mellitus and hypertension: insights from the Taiwan Biobank
by: Fa–Chen Lin, et al.
Published: (2025-05-01)

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway
by: Qian Sun, et al.
Published: (2024-12-01)

Buck-Boost/Forward Hybrid Converter for PV Energy Conversion Applications
by: Sheng-Yu Tseng, et al.
Published: (2014-01-01)

Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
by: Nadja Ballin, et al.
Published: (2025-04-01)

Enhanced tumor suppression in patient-derived temozolomide-resistant glioblastoma cells using a combination treatment of Olaparib and FK866
by: Xiaowei Sha, et al.
Published: (2025-07-01)

Homologous tumor cell exosome-based drug delivery system co-delivering temozolomide and resveratrol for orthotopic glioblastoma therapy
by: Xuemei Wang, et al.
Published: (2025-12-01)

Electrochemical modulation of tau protein phosphorylation levels with biomimetic polyaniline membranes
by: Shang-Chi Chien, et al.
Published: (2025-06-01)

STAT3/TGFBI signaling promotes the temozolomide resistance of glioblastoma through upregulating glycolysis by inducing cellular senescence
by: Yanbin Zhang, et al.
Published: (2025-04-01)

99mTc-Tetrofosmin uptake correlates with the sensitivity of glioblastoma cell lines to temozolomide
by: George Alexiou, et al.
Published: (2017-01-01)

COX-2 Inhibition in Glioblastoma Cells Counteracts Resistance to Temozolomide by Inducing Oxidative Stress
by: Francesca Rosaria Augello, et al.
Published: (2025-04-01)

Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
by: Fahad E. Alotaibi, et al.
Published: (2013-01-01)

The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
by: Made Agus Mahendra Inggas, et al.
Published: (2025-03-01)

Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines
by: Chih-Hung Lee, et al.
Published: (2024-11-01)

RETRACTED: Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair
by: Jianheng Wu, et al.
Published: (2021-02-01)

A Fragile Watermarking Scheme for Authenticity Verification of 3D Models in GLB Format
by: Marcin Matczuk, et al.
Published: (2025-06-01)

Clusterin-mediated polarization of M2 macrophages: a mechanism of temozolomide resistance in glioblastoma stem cells
by: Jianping Wen, et al.
Published: (2025-03-01)

Shape Optimization of Multi-chamber Acoustical Plenums Using the BEM, Neural Networks, and the GA Method
by: Ying-Chun CHANG, et al.
Published: (2015-10-01)

Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma
by: Xin Luo, et al.
Published: (2025-01-01)

α-synuclein expression in glioblastoma restores tumor suppressor function and rescues temozolomide drug resistance
by: Eric Duplan, et al.
Published: (2025-03-01)

Resveratrol and temozolomide induce apoptosis and suppress proliferation in glioblastoma cells via the apoptotic signaling pathway
by: Görkem Tutal Gürsoy, et al.
Published: (2025-08-01)

Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
by: Sarah E Williford, et al.
Published: (2021-01-01)

DNA methylation remodeling in temozolomide resistant recurrent glioblastoma: comparing epigenetic dynamics in vitro and in vivo
by: Michela Buonaiuto, et al.
Published: (2025-07-01)

Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
by: Diego Carrillo-Beltrán, et al.
Published: (2025-01-01)

A quantitative characterization of the heterogeneous response of glioblastoma U-87 MG cell line to temozolomide
by: Pragyesh Dixit, et al.
Published: (2025-05-01)

Late complications of congenital nasolacrimal duct obstruction in a Taiwanese family
by: Chih-Heng Hung, et al.
Published: (2020-12-01)